Samsung medical center
Seoul, South Korea
NCT Number: NCT01491503
The purpose of this study is to evaluate the drug-drug interaction between montelukast sodium and levocetirizine dihydrochloride in healthy male volunteers.
Looking for future studies?
Notify Me20 year–55 year
Male
Interventional
Phase 1
Seoul, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Levocetirizine dihydrochloride 5mg. PO. Single dose.
Montelukast sodium 10mg. PO. Single dose.
Montelukast sodium 10mg & levocetirizine dihydrochloride 5mg PO. Single dose.
Time frame: 0-36hrs
Time frame: 0-36hrs
Time frame: 0-36hrs
Time frame: 0-36hrs
Time frame: 0-36hrs
Hanmi Pharmaceutical Company Limited
Industry
Open Label, Randomized, 6-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Montelukast Sodium and Levocetirizine Dihydrochloride in Health Male Volunteers
Acronym: MOLZ
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06861829
Healthy
Biberach, Germany
View Trial DetailsNCT06429137
Healthy
Biberach, Germany
View Trial DetailsNCT01520792
Healthy
Clermont-Ferrand, France
View Trial DetailsNCT07542886
Healthy
Brussels, Bruxelles-capitale, Région de, Belgium
View Trial Details